Dental Imaging Market Analysis 2026
19 Companies · CBCT · Panoramic · Intraoral · AI Imaging
Strategic positioning, financial intelligence, market opportunities, and competitive threat assessment for the global dental imaging sector.
Global dental CBCT imaging market projected at 9.4% CAGR ($1.18B in 2026 → $2.02B by 2030). AI in dental imaging growing in parallel at 22.3% CAGR. Source: Coherent Market Insights, May 2026.
Hardware purchase price range across each competitor's CBCT product line. Vatech's $45k–$85k entry pricing unlocks the solo practice segment where incumbents cannot compete.
Estimated Year-1 total cost of ownership including hardware, software subscriptions, installation, and maintenance. Based on verified 2026 pricing data. Source: DentalTI TCO Guide 2026.
Threat scoring across six competitive dimensions: market share, financial momentum, AI capability, product innovation, price accessibility, and digital marketing presence. Updated May 2026.
Annual revenue comparison. Dentsply Sirona's scale ($3.5B FY 2026 guidance) vs. Envista's $2.8B run rate and Vatech's profitable niche (~$352M annualized from Q4 2025). Sources: SEC filings, KOSDAQ.
Q1 2026 growth metrics. Envista (DEXIS parent) leads with 14.4% revenue growth and 50% EPS expansion. Dentsply showing Q4 2025 recovery at +6.2% YoY; in restructuring phase.
All three tracked competitors score near-zero on creator-driven digital channels. LinkedIn is the only platform with meaningful presence (Dentsply Sirona: 272K followers). This is the largest uncontested opportunity in the market. Data sourced May 8, 2026.
| Metric | Dentsply Sirona | DEXIS/Envista | Vatech |
|---|---|---|---|
| Annual Revenue / Run Rate | $3.5–3.6B (2026 guidance) | ~$2.8B (Q1 annualized) | ~$352M (Q4 annualized) |
| Most Recent Quarterly Revenue | $961M Q4 2025 (+6.2% YoY) | $705.5M Q1 2026 (+14.4% YoY) | ~$88M Q4 2025 (KOSDAQ) |
| EPS / Guidance 2026 | $1.40–$1.50 FY guidance | $0.36 Q1 adj. (+50% YoY); $1.35–$1.45 FY | N/A (KOSDAQ; KRW reporting) |
| Operating Margin | Under pressure; restructuring | 10.3% adj. operating margin Q1 | ~15.5% (2023 est.; no 2026 update) |
| CBCT Hardware Price Range | $95k–$130k+ (Orthophos SL/Axeos) | $60k–$95k (OP 3D Pro) | $45k–$85k (Green series) |
| Year-1 TCO (est.) | $110k–$170k (hardware + DS Core + service) | $75k–$120k (hardware + DTX Studio) | $55k–$100k (hardware + lower SaaS) |
| AI Strategy (2026) | Smart View–Detect; FDA-cleared May 12, 2026; PARL detection +46% vs. unassisted | Pearl AI native integration; 1,000+ PDS Health practices live (Jul 2025) | Clever One platform (FDA Aug 2025); Pearl alliance (Mar 2025) |
| Strategic Status | Return-to-Growth restructuring; FY guidance below historical | High-growth execution; strongest financial momentum | #1 US dental CT share; profitable niche; weak US marketing |
CAD/CAM & Digital Manufacturing
Competitive landscape for intraoral scanners, milling systems, 3D printing, and digital workflow platforms across 22 tracked companies.
Dental Software & AI Platforms
AI diagnostics, practice management software, patient engagement platforms, and revenue cycle tools across 26 tracked companies.
Dental Service Organizations
Financial profiles, location counts, ownership structures, and procurement behavior across 30 of the largest DSOs in North America.